D. Farrukh

Работ: 3

Tashkent Medical Park Llc, HOD Oncology Department, Tashkant, Uzbekistan

1. 75eP Mutational spectrum of KRAS, TP53, BRAF, ERBB2, and POLE in GI malignancies across diverse populations

   Nikhil Ghadyalpatil, Umut Dişel, O. Zilola +15

   СтатьяChromatin Remodeling and CancerESMO Open2025Цитирований: 0

   ABIABI:AkademIndex/openalex/2025.article.008761

2. Abstract 2510: Comprehensive genomic profiling drives precision oncology and expands accessibility to targeted therapies in Uzbek populations

   Zilola Avazovna Olimova, Gowhar Shafi, D. Farrukh +10

   СтатьяCancer Genomics and DiagnosticsCancer Research2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.010172

3. Abstract 3141: Integrative genomic analysis reveals pharmacogenomic determinants of chemotherapy response

   D. Farrukh, Yashodhara Bhattacharya, Mohan Uttarwar +8

   СтатьяPharmacogenetics and Drug MetabolismCancer Research2026Цитирований: 0

   ABIABI:AkademIndex/openalex/2026.article.010238